GET THE APP

..

Journal of Cancer Clinical Trials

ISSN: 2577-0535

Open Access

Advanced DNA-Biomacromolecule Sensor: Enhancing Sensitivity in Clinical Cancer Sample Detection

Abstract

John Paulisen*

An ultrasensitive DNA-biomacromolecule system or technology has the capability to detect and analyze DNA molecules with exceptional sensitivity. DNA, serving as the fundamental genetic material in living organisms, holds critical significance in numerous biological processes and finds extensive applications in diagnostics and research. Ultrasensitive DNA-biomacromolecule technologies are specifically engineered to identify and quantify minute amounts of DNA molecules within a given sample. Employing diverse detection methodologies such as fluorescence, electrochemical sensing, nanopore sequencing, or amplification techniques like polymerase chain reaction, these technologies enable scientists to achieve remarkably precise and sensitive detection of DNA molecules, even when present in exceedingly low concentrations.

HTML PDF

Share this article

Google Scholar citation report
Citations: 95

Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report

Journal of Cancer Clinical Trials peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward